Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06129474 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Deprescribing Inappropriate Proton Pump Inhibitors

Study acronym: DROPIT
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Eligibility criteria expanded, about 25 wordsv7
  2. Eligibility criteria shortened, about 2 wordsv6
  3. Eligibility criteria revisedv5
  4. Eligibility criteria revised
    • Secondary endpoints: details revised at 1 of 13 entries
    v4
  5. Study sites: 3 to 2v3
  6. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Jan 1, 2024 to Oct 1, 2024
    • Study sites: 1 to 3
    v2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The DROPIT Trial is an interventional, open-labelled, cluster-randomized controlled trial conducted in the Swiss primary care setting. It aims to evaluate an intervention to guide the deprescribing of inappropriate proton-pump inhibitors (PPIs). Therefore, the trial investigates whether the study intervention leads to the deprescribing of inappropriate PPI prescription while ensuring noninferiority safety, in comparison to usual care. Additionally, the trail aims to investigate the intervention's impact on other clinical aspects, as well as addressing features of the implementation of the intervention and its cost-effectiveness.
Trial Details
NCT Number NCT06129474
Lead Sponsor University of Bern
Collaborators: Swiss National Science Foundation, University of Zurich, University of Basel, Insel Gruppe AG, University Hospital Bern, Patientenstelle Zürich, Patientenstelle Basel, Centre Hospitalier Universitaire Vaudois
Conditions
(from sponsor)		 Inappropriate Prescribing, Reflux Disease, Proton Pump Inhibitors
Related terms Gastroesophageal Reflux
Enrollment 400 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov